Search research articles
Contact Us
Filters
Showing results (171-180 of 277) with videos related to
Page
of 28
Sort By:
The Journal of Rheumatology
|
September 17, 2017
Genetic Determinants of Radiographic Knee Osteoarthritis in African Americans
Youfang Liu, Michelle S Yau, Laura M Yerges-Armstrong, et al.
Plos One
|
January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
Siri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2005
Hip fracture in women without osteoporosis
Stacey A Wainwright, Lynn M Marshall, Kristine E Ensrud, et al.
Ophthalmology
|
May 4, 2004
Higher risk of multiple falls among elderly women who lose visual acuity
Anne L Coleman, Katie Stone, Susan K Ewing, et al.
The Journal of Rheumatology
|
April 17, 2013
Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program
Michael E Weinblatt, Larry W Moreland, Rene Westhovens, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures
Ethel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 21, 2020
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
Yusuf Yazici, Timothy E McAlindon, Allan Gibofsky, et al.
Lancet (London, England)
|
August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
Thomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, et al.
The New England Journal of Medicine
|
February 24, 2006
Response to expression of concern regarding VIGOR study
Claire Bombardier, Loren Laine, Ruben Burgos-Vargas, et al.
Journal of the American Geriatrics Society
|
August 26, 2009
Visual field loss and risk of fractures in older women
Anne L Coleman, Steven R Cummings, Kristine E Ensrud, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 277) with videos related to
Sort By:
Page
of 28
The Journal of Rheumatology
|
September 17, 2017
Genetic Determinants of Radiographic Knee Osteoarthritis in African Americans
Youfang Liu, Michelle S Yau, Laura M Yerges-Armstrong, et al.
Plos One
|
January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
Siri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2005
Hip fracture in women without osteoporosis
Stacey A Wainwright, Lynn M Marshall, Kristine E Ensrud, et al.
Ophthalmology
|
May 4, 2004
Higher risk of multiple falls among elderly women who lose visual acuity
Anne L Coleman, Katie Stone, Susan K Ewing, et al.
The Journal of Rheumatology
|
April 17, 2013
Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program
Michael E Weinblatt, Larry W Moreland, Rene Westhovens, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures
Ethel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 21, 2020
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
Yusuf Yazici, Timothy E McAlindon, Allan Gibofsky, et al.
Lancet (London, England)
|
August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
Thomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, et al.
The New England Journal of Medicine
|
February 24, 2006
Response to expression of concern regarding VIGOR study
Claire Bombardier, Loren Laine, Ruben Burgos-Vargas, et al.
Journal of the American Geriatrics Society
|
August 26, 2009
Visual field loss and risk of fractures in older women
Anne L Coleman, Steven R Cummings, Kristine E Ensrud, et al.
Page
of 28